Paragon Capital Management (Colorado)’s AbbVie ABBV Stock Holding History

Paragon Capital Management (Colorado)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Sell	6,382 -43	-0.7%	-$9.25K	0.3%	35
2026 Q1	$1.4M	Sell	6,425 -247	-4%	-$54.8K	0.29%	36
2025 Q4	$1.52M	Sell	6,672 -98	-1%	-$22.3K	0.3%	35
2025 Q3	$1.57M	Sell	6,770 -744	-10%	-$152K	0.29%	33
2025 Q2	$1.39M	Buy	7,514 +6	+0.1%	+$1.11K	0.25%	38
2025 Q1	$1.57M	Buy	7,508 +6	+0.1%	+$1.17K	0.32%	30
2024 Q4	$1.33M	Sell	7,502 -57	-0.8%	-$10.5K	0.27%	36
2024 Q3	$1.49M	Sell	7,559 -270	-3%	-$50.4K	0.29%	32
2024 Q2	$1.34M	Sell	7,829 -94	-1%	-$15.6K	0.25%	32
2024 Q1	$1.44M	Sell	7,923 -443	-5%	-$76.3K	0.26%	33
2023 Q4	$1.3M	Sell	8,366 -34	-0.4%	-$4.96K	0.27%	33
2023 Q3	$1.25M	Buy	8,400 +5	+0.1%	+$734	0.28%	32
2023 Q2	$1.13M	Buy	8,395 +4	+0%	+$587	0.25%	37
2023 Q1	$1.34M	Buy	8,391 +5	+0.1%	+$764	0.31%	31
2022 Q4	$1.36M	Sell	8,386 -21	-0.2%	-$3.22K	0.36%	28
2022 Q3	$1.13M	Sell	8,407 -131	-2%	-$18.8K	0.32%	27
2022 Q2	$1.31M	Sell	8,538 -546	-6%	-$83.4K	0.37%	28
2022 Q1	$1.47M	Sell	9,084 -300	-3%	-$43.6K	0.28%	32
2021 Q4	$1.27M	Sell	9,384 -139	-1%	-$16.4K	0.2%	36
2021 Q3	$1.03M	Buy	9,523 +280	+3%	+$32K	0.18%	39
2021 Q2	$1.04M	Buy	9,243 +5	+0.1%	+$563	0.49%	26
2021 Q1	$1M	Sell	9,238 -55	-0.6%	-$5.88K	0.52%	24
2020 Q4	$996K	Buy	9,293 +60	+0.6%	+$5.77K	0.54%	23
2020 Q3	$809K	Hold	9,233	–	–	0.44%	26
2020 Q2	$906K	Buy	9,233 +917	+11%	+$80.7K	0.39%	25
2020 Q1	$634K	Hold	8,316	–	–	0.36%	26
2019 Q4	$736K	Hold	8,316	–	–	0.39%	29
2019 Q3	$630K	Hold	8,316	–	–	0.35%	34
2019 Q2	$605K	Sell	8,316 -50	-0.6%	-$3.93K	0.34%	37
2019 Q1	$674K	Hold	8,366	–	–	0.41%	28
2018 Q4	$771K	Sell	8,366 -18	-0.2%	-$1.58K	0.37%	26
2018 Q3	$793K	Buy	8,384 +3	+0%	+$284	0.68%	27
2018 Q2	$776K	Buy	8,381 +65	+0.8%	+$6.35K	0.69%	26
2018 Q1	$787K	Sell	8,316 -1,934	-19%	-$212K	0.35%	32
2017 Q4	$991K	Buy	10,250 +2	+0%	+$188	0.39%	30
2017 Q3	$911K	Buy	10,248 +1,657	+19%	+$126K	0.35%	35
2017 Q2	$623K	Hold	8,591	–	–	0.29%	37
2017 Q1	$560K	Buy	+8,591	New	+$540K	0.25%	48
2016 Q3	$617K	Sell	9,775 -350	-3%	-$22.7K	0.33%	33
2016 Q2	$627K	Hold	10,125	–	–	0.34%	34
2016 Q1	$578K	Sell	10,125 -470	-4%	-$26.2K	0.35%	31
2015 Q4	$628K	Hold	10,595	–	–	0.39%	31
2015 Q3	$576K	Buy	10,595 +200	+2%	+$13K	0.35%	36
2015 Q2	$698K	Hold	10,395	–	–	0.44%	28
2015 Q1	$609K	Sell	10,395 -200	-2%	-$12.1K	0.4%	30
2014 Q4	$693K	Sell	10,595 -42	-0.4%	-$2.65K	0.48%	26
2014 Q3	$614K	Buy	10,637 +400	+4%	+$22.2K	0.43%	29
2014 Q2	$578K	Sell	10,237 -150	-1%	-$7.87K	0.4%	32
2014 Q1	$534K	Sell	10,387 -776	-7%	-$39.2K	0.39%	32
2013 Q4	$590K	Hold	11,163	–	–	0.44%	28
2013 Q3	$499K	Hold	11,163	–	–	0.39%	29
2013 Q2	$461K	Buy	+11,163	New	+$488K	0.37%	31

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Paragon Capital Management (Colorado)'s ABBV Position: Q2 2026 in Review

Paragon Capital Management (Colorado) reduced its AbbVie (ABBV) stake by 0.67% in Q2 2026, selling an estimated $9.25K and leaving 6,382 shares worth $1.61M. The position accounts for 0.3% of the portfolio, ranked #35.

Paragon Capital Management (Colorado) first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Paragon Capital Management (Colorado) held 6,382 shares of AbbVie worth $1.61M as of Q2 2026.
Paragon Capital Management (Colorado) sold 43 AbbVie shares in Q2 2026, an estimated $9.25K.
AbbVie made up 0.3% of Paragon Capital Management (Colorado)'s portfolio in Q2 2026, its #35 holding.
Paragon Capital Management (Colorado) first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q2 2026, filed 29 Jul 2026.